Author:
Nousiainen T,Jantunen E,Vanninen E,Hartikainen J
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Alberts DS, Garcia DJ (1997) Safety aspects of pegylated liposomal doxorubicin in patients with cancer. Drugs 54: Suppl 4 30–35
2. Alexander J, Dainiak N, Berger HJ, Goldman L, Johnstone D, Reduto L, Duffy T, Schwartz P, Gottschalk A, Zaret BL (1979) Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. N Engl J Med 300: 278–283
3. Bauch M, Ester A, Kimura B, Victorica BE, Kedar A, Phillips MI (1992) Atrial natriuretic peptide as a marker for doxorubicin-induced cardiotoxic effects. Cancer 69: 1492–1497
4. Billingham ME, Bristow MR (1984) Evaluation of anthracycline cardiotoxicity: predictive ability and functional correlation of endomyocardial biopsy. Cancer Treat Symp 3: 71–76
5. Carrio I, Estorch M, Berná L, Lopez-Pousa J, Tabernero J, Torres G (1995) Indium-111-antimyosin and iodine-123-MIBG studies in early assessment of doxorubicin cardiotoxicity. J Nucl Med 36: 2044–2049
Cited by
131 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献